COGENT BIOSCIENCES (COGT) 8-K Summary

This Form 8-K, dated November 3, 2025, confirms the release of quarterly financial results.

• Material Event: Item 2.02 signals the issuance of a press release detailing financial performance for the period ended September 30, 2025.
• Investor Action Required: The specific financial metrics, performance data, and guidance are not detailed in this filing itself but are incorporated by reference in Exhibit 99.1 (the press release).
• Regulatory Note: Information furnished under Item 2.02 is generally not deemed “filed” und